|
||
Original Article |
Correspondence to: David P. Andrew, LeukoSite, Inc., 215 First St., Cambridge, MA 02142. Tel:617-621-9350 ext. 2250 Fax:617-621-9380 E-mail:dpandrew{at}hotmail.com.
TECK (thymus-expressed chemokine), a recently described CC chemokine expressed in thymus and small intestine, was found to mediate chemotaxis of human G proteincoupled receptor GPR-9-6/L1.2 transfectants. This activity was blocked by antiGPR-9-6 monoclonal antibody (mAb) 3C3. GPR-9-6 is expressed on a subset of memory
4ß7high intestinal trafficking CD4 and CD8 lymphocytes. In addition, all intestinal lamina propria and intraepithelial lymphocytes express GPR-9-6. In contrast, GPR-9-6 is not displayed on cutaneous lymphocyte antigenpositive (CLA+) memory CD4 and CD8 lymphocytes, which traffic to skin inflammatory sites, or on other systemic
4ß7-CLA- memory CD4/CD8 lymphocytes. The majority of thymocytes also express GPR-9-6, but natural killer cells, monocytes, eosinophils, basophils, and neutrophils are GPR-9-6 negative. Transcripts of GPR-9-6 and TECK are present in both small intestine and thymus. Importantly, the expression profile of GPR-9-6 correlates with migration to TECK of blood T lymphocytes and thymocytes. As migration of these cells is blocked by antiGPR-9-6 mAb 3C3, we conclude that GPR-9-6 is the principal chemokine receptor for TECK. In agreement with the nomenclature rules for chemokine receptors, we propose the designation CCR-9 for GPR-9-6. The selective expression of TECK and GPR-9-6 in thymus and small intestine implies a dual role for GPR-9-6/CCR-9, both in T cell development and the mucosal immune response.
Key Words:
chemokine,
4ß7, cutaneous lymphocyte antigen, memory, intestinal
This article has been cited by other articles:
| TABLE OF CONTENTS |
|